HomeMANKIND • NSE
Mankind Pharma Ltd
₹2,366.60
Jun 9, 2:25:43 PM GMT+5:30 · INR · NSE · Disclaimer
StockIN listed security
Previous close
₹2,352.40
Day range
₹2,353.00 - ₹2,378.90
Year range
₹1,901.05 - ₹3,054.80
Market cap
976.63B INR
Avg Volume
324.96K
P/E ratio
48.21
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR)Mar 2025Y/Y change
Revenue
30.79B26.15%
Operating expense
17.52B60.50%
Net income
4.21B-10.71%
Net profit margin
13.66-29.22%
Earnings per share
10.29-12.35%
EBITDA
6.08B1.68%
Effective tax rate
16.77%
Total assets
Total liabilities
(INR)Mar 2025Y/Y change
Cash and short-term investments
22.45B-33.70%
Total assets
277.60B132.04%
Total liabilities
131.91B452.53%
Total equity
145.68B
Shares outstanding
412.52M
Price to book
6.77
Return on assets
Return on capital
6.58%
Net change in cash
(INR)Mar 2025Y/Y change
Net income
4.21B-10.71%
Cash from operations
Cash from investing
Cash from financing
Net change in cash
Free cash flow
About
Mankind Pharma is an Indian multinational pharmaceutical and healthcare product company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications. As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. The company derived 97% of its operating revenue from the Indian market, where it is reportedly the fourth largest pharmaceutical company by domestic sales. Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Wikipedia
Founded
1991
Employees
19,540
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu